Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem Cell MobilizationLeukapheresisGranulocyte Colony-Stimulating FactorHematologic NeoplasmsStem CellsTissue DonorsBlood Component RemovalHematopoietic Stem CellsAntigens, CD34Stem Cell TransplantationTreatment OutcomeImmunosuppressive AgentsGraft SurvivalMelphalanCombined Modality TherapyBlood DonorsCyclophosphamideMultiple MyelomaBusulfanAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationBlood CellsHistocompatibilityRecurrenceHistocompatibility TestingLymphoma, Non-HodgkinMyeloablative AgonistsBlood Cell CountCytomegalovirus InfectionsEtoposideTransplantation ChimeraRetrospective StudiesWhole-Body IrradiationAntineoplastic Agents, AlkylatingRemission InductionThiotepaTime FactorsHematopoiesisLeukemiaTransplantationOpportunistic InfectionsSalvage TherapyBone Marrow PurgingInfectionSurvival RateLiving DonorsDisease-Free SurvivalVidarabineImmunocompromised HostSurvival AnalysisIfosfamideAnemia, AplasticHematologic DiseasesHodgkin DiseasePlatelet CountEmbryonic Stem CellsFlow CytometryNeoplasmsLeukocyte TransfusionCytarabineLeukocytes, MononuclearLeukemia, Myeloid, AcuteCell SeparationLeukemia, Myelogenous, Chronic, BCR-ABL PositivePOEMS SyndromeLymphocyte DepletionAdult Stem CellsTransplantation, IsogeneicAmyloidosisLymphomaRecombinant ProteinsImmunophenotypingCyclosporineFatal OutcomePlatelet TransfusionCytomegalovirusImmunomagnetic SeparationFollow-Up StudiesT-LymphocytesVincristineBone MarrowBone Marrow CellsFeasibility StudiesLeukocyte CountBone Marrow DiseasesAcute DiseaseProspective StudiesCells, CulturedKidney TransplantationProchlorperazineMyelodysplastic SyndromesNeutropeniaHLA Antigens